Search for: "Teva Pharmaceuticals LLC" Results 161 - 180 of 254
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
15 May 2023, 7:21 am by Dennis Crouch
. = = = = The court also denied certiorari in the skinny-label FDA-Patent case of Teva Pharmaceuticals USA, Inc. v. [read post]
1 Jun 2009, 7:01 pm
The USPTO's reexamination is in parallel to a pending court case where a ruling is expected from a trial in which Merck is asserting the patent against Teva Pharmaceuticals, who is challenging the patent. [read post]
13 Jan 2010, 3:00 am
Actavis Elizabeth LLC (Docket Report) US: Inclusion of Pay-for-Delay ban in Health Care Bill urged; FTC to hold press conference announcing pay-for-delay analysis (FDA Law Blog) US: Drug molecules going off patent in 2010 (Patentcircle)   Products Cipramil (Citalopram) - EU: Commission opens antitrust investigation into pharmaceutical company Lundbeck (EPLAW) (Managing IP) (GenericsWeb) Hectorol (Doxercalciferol) - US: Genzyme files patent infringement complaint against Cobrek… [read post]
17 Nov 2022, 6:15 am by Levin Papantonio
On top of the pharmacy settlements, in July 2022, pharmaceutical companies Teva Pharmaceuticals announced its agreement to pay $4.25 billion, and Allergan struck an agreement to pay $2.37 billion to resolve national opioid cases, The New York Times reported.With today’s announced agreement from Walmart, the total amount of settlements in this phase of opioid litigation has reached more than $20 billion with a total recovery of almost $60 billion. [read post]
27 Mar 2014, 6:07 am by John Elwood
  Patent-infringement case Teva Pharmaceuticals USA, Inc. v. [read post]
22 Mar 2011, 4:21 pm by Marie Louise
General New IP resource for Pharma, Biotech and Chem – Compulsory licences, comparing national requirements (IP Think Tank) WIPO and India partner to protect traditional knowledge from misappropriation (WIPO) UN Rapporteur for the Right to Health asked to intervene in the TPP negotiation (KEI) Patents and doctors, and the USTR TPP text (KEI) Biotech industry losing interest in the therapeutic potential of RNAi (Patent Docs) India: The curious case of the ‘data exclusivity’ volte… [read post]
24 Sep 2010, 1:22 pm by Stefanie Levine
Patent No. 7,126,008 owned by Teva Pharmaceutical Industries Ltd. and entitled CARVEDILOL. [read post]
17 Mar 2020, 1:32 pm by Noble McIntyre
One Lot of Topotecan Injection 4 mg/4 mL (1 mg/mL) has been recalled by Teva Pharmaceuticals due to the presence of particulate matter. [read post]
1 Apr 2013, 8:29 am by Gene Quinn
” Upon receiving this reissue patent, Pfizer immediately filed a lawsuit against Teva Pharmaceuticals USA, Inc.; Mylan Pharmaceuticals Inc.; Watson Laboratories, Inc.; Lupin Pharmaceuticals, USA, Inc.; Apotex Corp.; and Apotex, Inc. in the United States District Court for the Eastern District of Virginia for infringement of the reissue patent. [read post]
29 Apr 2014, 1:39 pm by Barry Barnett
The Supreme Court today granted certiorari in Teva Pharmaceuticals USA, Inc. v. [read post]
28 May 2008, 8:56 am
Teva Pharmaceutical, the world's biggest maker of generic drugs, said on May 6 that it was taking a $55 million charge for ARSs it holds, which totaled $334 million as of March 31. [read post]
16 Jan 2017, 5:44 pm by Dennis Crouch
Teva Pharmaceuticals USA, Inc., et al. [read post]
3 Mar 2015, 1:55 am
  Indeed, the cross-undertaking was ultimately granted in favour of the Actavis group, the Teva group and Dr Reddy’s Laboratories, in addition to the public bodies. [read post]